170503 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants Molecules with a "CD"-designation not provided for elsewhere in
CEACAM1 MEDIATED PROTECTIVE IMMUNITY
#602METHOD FOR IMPROVED HEPATOCELLULAR CANCER DIAGNOSIS
#603AML antigens and uses thereof
#604Prostate cancer-associated secreted proteins
#605Follistatin-related protein 3 for diagnosis and prognosis of renal injury and renal failure
#606Use of soluble CD146 as a biomarker to select in vitro-fertilized embryo for implantation in a mammal
#607Methods for monitoring polymorphonuclear myeloid derived suppressor cells
#608Methods of determining interferon having direct inhibitory effects on tumors and uses thereof
#609Anti-PD-L1 antibodies
#610KIDNEY FUNCTION BIOMARKERS
#611Antibody molecules to PD-1 and uses thereof
#612DIAGNOSTIC TEST INVOLVING ANTI-CD25-ADC
#613TOLL-LIKE RECEPTOR 2 BINDING EPITOPE AND BINDING MEMBER THERETO
#614Bi-functional arginine-glycine-aspartic acid (RGD) peptides and methods to promote angiogenesis
#615Serum biomarker panels for bipolar disorder
#616Methods and compositions for identifying leukemic stem cells
#617NOVEL METHOD FOR ANALYZING CIRCULATING TUMOR CELLS OF A PATIENT FOR THE PRESENCE OF METASTASIS-INITIATING CELLS
#618Use of CD24 for lowering low-density lipoprotein cholesterol levels
#619Multiples multiplex immunohistochemical assay using primary antibodies of the same host species
#620Antibodies against signal-regulatory protein alpha and methods of use
#621THERMOCHEMICAL-BASED ANTIBODY INACTIVATION METHODS AND SYSTEMS
#622Use of CD36 to identify cancer subjects for treatment
#623Antibody molecules to LAG-3 and uses thereof
#624Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
#625Immunohistochemical assay for detecting expression of programmed death ligand 1 (PD-L1) in tumor tissue
#626Biomarker panel for diagnosing cancer
#627Biomarker for diagnosis of extrahepatic bile duct carcinoma, intrahepatic bile duct carcinoma, or gallbladder carcinoma
#628Erythrocyte-derived extracellular vesicles as a biomarker for clinically assessing Parkinson's disease
#629DIAGNOSTIC METHOD
#630METHODS FOR MONITORING POLYMORPHONUCLEAR MYELOID DERIVED SUPPRESSOR CELLS, AND COMPOSITIONS AND METHODS OF TREATMENT OF CANCER
#631METHOD OF DISTINGUISHING MESENCHYMAL STEM CELLS AND METHOD OF DETERMINING PURITY OF MESENCHYMAL STEM CELLS
#632COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS
#633Treating conditions associated with metabolic syndrome
#634Neuropilin-1 specific binding peptide, fusion protein fused with same, and use thereof
#635IL-10-PRODUCING CD4+ T CELLS AND USES THEREOF
#636Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#637MOLECULAR PROFILING FOR CANCER
#638CD9 AS A THERAPEUTIC TARGET FOR HEMATOLOGIC MALIGNANCIES
#639Treating mental disorders
#640Treating cancer
#641Treating conditions associated with sepsis
#642Treating respiratory conditions
#643Treating multiple sclerosis
#644Methods of delivering DLL3 antibody drug conjugates
#645Methods of making DLL3 antibody drug conjugates
#646MULTIPLEX ASSAY FOR IMPROVED SCORING OF TUMOR TISSUES STAINED FOR PD-L1
#647METHOD FOR INCREASING NUMBER OF STEM CELLS IN HUMAN OR ANIMAL BODIES
#648Anti-DLL3 antibody drug conjugates and methods of use
#649Preparing antigen-specific T cells using a self-enclosed processing system that contains both a centrifuge and a magnetic separation column
#650PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
#651Systems and Methods for Detecting a Biological Condition
#652Anti-DLL3 antibody drug conjugates
#653METHOD FOR DETECTING MOLECULES THAT INHIBIT THE INTERACTION OF CD36 PROTEIN WITH AMYLOID BETA
#654METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#655Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies
#656Methods For Screening Therapeutic Compounds
#657Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics
#658Biomarker And Therapy Intervention For Malignancy Risk Patients
#659Cell identification method
#660Systems and methods for determining a chemical state
#661Methods of reducing viscosity of biological samples
#662B-cell antigen presenting cell assay
#663Anti-CD39 antibodies and uses thereof
#664Method for identifying a compound useful with myosin regulatory light chain polypeptide antibody for treatment of an inflammatory disease
#665PRO-ANGIOGENIC AND ANTI-ANGIOGENIC HEMATOPOIETIC PROGENITOR CELL POPULATIONS
#666DIAGNOSIS OF AN AUTOIMMUNE DISEASE USING DETECTION OF ANTIBODIES DIRECTED AGAINST C5A-RECEPTOR
#667Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient
#668Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand
#669Compositions and methods for treating eye infections and disease
#670COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#671Anti-MFI2 antibodies and methods of use
#672Detection of an immune response
#673Diagnostic method for parkinson's disease and lewy body dementia
#674Kits containing DLL3 antibody drug conjugates
#675Methods and materials for treating renal cell carcinoma
#676Compositions and methods for treating malignancies
#677Immunohistochemistry scoring methods and compositions
#678Anti-DLL3 antibody drug conjugates
#679ANTI-MUTANT CALRETICULIN ANTIBODIES AND THEIR USE IN THE DIAGNOSIS AND THERAPY OF MYELOID MALIGNANCIES
#680Targeting breast cancer therapy based on stromal subtypes and CD146 composition
#681Levels of CXCL10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS
#682Anti-DLL3 antibody drug conjugates for treating cancer
#683Methods of making DLL3 antibody drug conjugates
#684Methods of delivering DLL3 antibody drug conjugates
#685Anti-DLL3 antibody drug conjugates
#686Compositions for modulating cancer stem cells and uses therefor
#687METHODS FOR MONITORING CD4+ T-HELPER TYPE 1 RESPONSE IN CANCER AND IMMUNE RESTORATION
#688METHOD FOR SCREENING DRUG-SACCHARIDE CONJUGATES
#689Corneal endothelial cell marker
#690METHOD OF PREDICTING RESPONSE OF A HUMAN SUBJECT SUFFERING FROM MULTIPLE SCLEROSIS TO INTERFERON BETA, (IFN-ß)
#691METHODS AND COMPOSITIONS FOR OBTAINING A TUBERCULOSIS ASSESSMENT IN A SUBJECT
#692Assay for detection of chimeric antigen receptor T cells
#693Diagnosis and treatment of breast cancer
#694POTENCY ASSAY FOR THERAPEUTIC AGENTS
#695ANTI-PD-1 MONOCLONAL ANTIBODY AND OBTAINING METHOD THEREFOR
#696Internalizing human monoclonal antibodies targeting prostate and other cancer cells
#697Human monoclonal antibodies against CD25
#698Single-chain variable fragment anti-CD133 antibodies and uses thereof
#699SIGNATURES AND DETERMINANTS FOR DIAGNOSING INFECTIONS IN NON-HUMAN SUBJECTS AND METHODS OF USE THEREOF
#700Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators
#701PREDICTING RESPONSE TO A VEGF ANTAGONIST
#702HEPATOCELLULAR CARCINOMA MARKER
#703METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#704Method for treating rheumatoid arthritis
#705Surrogates of post-translationally modified proteins and uses thereof
#706Anti-MUC1 antibody or antigen-binding fragment thereof and uses thereof
#707CEACAM5 PEPTIDES FOR CROHN'S DISEASE
#708CANCER TREATMENT
#709Compositions and methods for treating eye infections and disease
#710Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders
#711Targeting DNA-PKcs and B7-H1 to treat cancer
#712Methods of treating a kit-associated cancer by administering anti-kit antibodies
#713Methods and kits for detecting brain injury
#714RECEPTORS OF RSPO2 AND RSPO3
#715Cell surface signature for processing cardiomyocyte subsets from heterogeneous cell samples
#716METHOD FOR TEST ON DIABETIC NEPHROPATHY
#717TEST METHOD ON RENAL DISEASES
#718Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
#719Aptamers specific for TLR-4 and uses thereof
#720Molecular analysis of tumor samples
#721Detoxification of microbial virulence factors in oral cavity
#722Biological substance detection method
#723Image analysis and measurement of biological samples
#724USE OF BIOMARKERS FOR DETECTION OF EXCESSIVE ALCOHOL USE
#725Methods and reagents for the assessment of gestational diabetes
#726Self-contained disposable tubing set for sterile preparation of cells by culturing, centrifugation, and column chromatography
#727Combination of CD95/CD95L inhibition and Cancer Immunotherapy
#728Methods and materials for reducing supression of immune function
#729Methods for diagnosing and treating subjects for pulmonary exacerbation
#730NEW BIOMARKER FOR OUTCOME IN AML PATIENTS
#731Method for identifying and obtaining activated T-cells that have a demethylated Foxp3 TSDR region
#732Method for diagnosing fibromyalgia syndrome, and kit therefor
#733PRIMITIVE AND PROXIMAL HEPATIC STEM CELLS
#734CELL LINE-BASED REDIRECTED T-CELL CYTOTOXICITY ASSAY
#735PVRIG polypeptides and methods of treatment
#736METHODS OF ISOLATING DISTINCT PANCREATIC CELL TYPES
#737Methods of diagnosing and treating tuberculosis
#738METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIA
#739System and method for capturing and analyzing cells
#740Method for the serological diagnosis of rheumatoid arthritis
#741METHOD FOR SUGGESTING THE STAGE OF PROGRESSION OF PANCREATIC CANCER
#742FUNCTIONAL LIGANDS TO TARGET MOLECULES AND METHODS
#743Endoglin antibodies
#744TLR-4 BASED ELECTROCHEMICAL BIOSENSOR
#745SURROGATES OF POST-TRANSLATIONALLY MODIFIED PROTEINS AND USES THEREOF
#746Image analysis and measurement of biological samples
#747Cell-surface marker of early MSC aging
#748DETECTING PODOCYTE INJURY IN DIABETIC NEPHROPATHY AND GLOMERULONEPHRITIS
#749Anti-CD33 antibodies and immunoconjugates
#750Non-invasive monitoring cancer using integrated microfluidic profiling of circulating microvesicles
#751Anti-DLL3 antibody drug conjugates for treating cancer
#752METHOD FOR DIGANOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36
#753Method for evaluation of function of phagocyte
#754Immune monitoring to predict and prevent infection
#755METHOD OF EVALUATION OF THE RELATIVE RISK OF DEVELOPING ATHEROSCLEROSIS IN PATIENTS
#756Non-Invasive Biomarker of Antibody-Mediated Allograft Rejection
#757Aptamer construct
#758Methods for testing anti-thrombotic agents
#759Genetically modified non-human animals and methods relating to innate immune system response detection
#760METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING TUMOR CELL MIMICS
#761Method for Detecting Lung Cancer
#762COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF MELANOMA USING PD-L1 ISOFORMS
#763Nano-plasmonic sensor for exosome detection
#764METHOD FOR THE ISOLATION, PURIFICATION AND AMPLIFICATION OF RENAL PROGENITORS CD133+CD24+ FROM THE URINE OF PATIENTS SUFFERING FROM RENAL DISEASES
#765DRUG DELIVERY SYSTEM
#766CD37-binding molecules and immunoconjugates thereof
#767ASSAY FOR PRIONS
#768SRM/MRM assay for subtyping lung histology
#769METHOD FOR PREDICTING THE SURVIVAL STATUS AND PROGNOSIS OF ESOPHAGEAL CANCER AND A KIT THEREOF
#770Bicalutamide analogs or (S)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis
#771Polynucleotides encoding anti-kit antibodies
#772TETRASPANIN CD82 AS A DIAGNOSTIC AND/OR THERAPEUTIC MODULE FOR XENOGRAFT RECOGNITION AND/OR REJECTION
#773METHODS AND REAGENTS FOR THE ASSESSMENT OF GESTATIONAL DIABETES
#774BIOMARKERS FOR MULTIPLE MYELOMA
#775Protein biomarker panels for detecting colorectal cancer and advanced adenoma
#776Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction
#777Anti-DR6 antibodies and methods of immune regulation
#778FGFR/PD-1 combination therapy for the treatment of cancer
#779Compositions and methods for diagnosing and treating an inflammation
#780Cancer markers and methods of use thereof
#781Compositions and methods for prostate cancer analysis
#782BIOMARKER FOR RHEUMATOID ARTHRITIS DIAGNOSIS OR ACTIVITY EVALUATION
#783Anti-PD-L1 monoclonal antibodies and fragments thereof
#784Corneal endothelial cell marker
#785Method for selecting an antigen-specific hybridoma
#786Reprogramming bone endothelial cells for use in bone angiogenesis and osteogenesis
#787Post-natal hematopoeitic endothelial cells and their isolation and use
#788Immunohistochemical assay for detection of CD3 and CD16
#789Methods, devices, and systems for sample analysis
#790METHOD OF ISOLATING CIRCULATING TUMOR CELLS
#791METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#792Device for concentration and separation of circulating tumor cells, and method for concentration and separation of circulating tumor cells
#793Automated method for sterile processing of cells by centrifugation and column chromatography
#794Method for determining quantity of biological material in tissue section
#795Single-chain variable fragment anti-CD133 antibodies and uses thereof
#796Inhibitor of breast cancer resistance protein (BCRP)
#797Methods for increasing palatability of pet foodstuff
#798USE OF DECTIN-1 ACTIVATORS FOR TREATMENT OF LIVER DISORDERS
#799Kit for diagnosis, prognosis, and monitoring the immune status, of patients with chronic inflammatory diseases
#800METHOD OF DIAGNOSING KIDNEY DAMAGE IN DIABETIC PATIENTS USING URINARY CD36 AS A BIOMARKER
#801B-cell antigen presenting cell assay
#802Method for evaluating the risk of mortality in patients who exhibit a systemic inflammatory response syndrome (SIRS) or sepsis
#803Methods and kits for predicting the risk of having a cardiovascular disease or event
#804Microfluidic system and method for isolating and quantifying at least one sub-population of cells from a population of cells
#805METHOD OF IDENTIFYING ADIPOSE STEM CELLS
#806Non-Glycosylated suPar Biomarkers and Uses Thereof
#807Methods for predicting and improving the survival of colorectal cancer patients
#808Methods and kits for identifying effector Treg cells
#809Diagnosis of respiratory tract infectious disease using urine specimens
#810Isolation, expansion and use of clonogenic endothelial progenitor cells
#811Simultaneous Assay of Target and Target-Drug Binding
#812Diagnosis of respiratory tract infectious disease using blood specimens
#813Anti-human CD26 monoclonal antibody or antigen-binding fragment thereof
#814METHODS FOR DIAGNOSING AND TREATING IMMUNE DISEASE
#815Non-human animals having a humanized cluster of differentiation 47 gene
#816ISOLATION AND PURIFICATION OF HEMATOPOIETIC STEM CELLS FROM POST-LIPOSUCTION LIPOASPIRATES
#817DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK
#818Method for detecting low concentrations of specific cell from high concentrations of cell populations, and method for collecting and analyzing detected cell
#819Detection of acute myeloid leukaemia (AML) leukaemic stem cells (LSC)
#820Method for the prognosis of survival time of a patient suffering from a solid cancer
#821Kits, compositions and methods for detecting a biological condition
#822Anti-mucin 1 binding agents and uses thereof
#823ANTIBODIES RECOGNIZING A CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS AND METHODS USING SAME
#824Methods and materials for treating renal cell carcinoma
#825Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy
#826Methods and devices for high throughput purification
#827Methods and compositions for the diagnosis and treatment of cancer
#828RHAMM, A CO-RECEPTOR AND ITS INTERACTIONS WITH OTHER RECEPTORS IN CANCER CELL MOTILITY AND THE IDENTIFICATION OF CANCER PROGNITOR CELL POPULATIONS
#829Hematopoietic cell phenotyping using circulating cell-free markers
#830Application of mesenchymal stem cells in prophylaxis or treatment of stress response-induced weakened immunity
#831Detection of an immune response
#832Predictive biomarker for cancer therapy
#833Isolation, expansion and use of clonogenic endothelial progenitor cells
#834Associating somatic gene mutations in glycophorin a with complex multifactorial diseases
#835Inflammatory disease treatment composition including anti-myosin regulatory light-chain polypeptide antibody
#836METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#837METHOD FOR DIAGNOSING AND TREATING CROHN'S DISEASE
#838METHODS FOR DIAGNOSIS OF CELIAC DISEASE
#839Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#840IMMUNOHISTOCHEMICAL ASSAY FOR DETECTING EXPRESSION OF PROGRAMMED DEATH LIGAND 1 (PD-L1) IN TUMOR TISSUE
#841Fusion proteins and immunoconjugates and uses thereof which are specific for glycophorin A
#842Method of isolating circulating tumor cells
#843Treating patients based on immune subtypes
#844Anti-DLL3 antibodies
#845COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
#846MEASURING CIRCULATING THERAPEUTIC ANTIBODY, ANTIGEN AND ANTIGEN/ANTIBODY COMPLEXES USING ELISA ASSAYS
#847Immunoassay for soluble PD-L1
#848Methods for determining responsiveness to an anti-CD47 agent
#849Methods for Predicting Cardiovascular Mortality Risk
#850SRM/MRM assay for subtyping lung histology
#851Biological assay of peptidoglycans
#852MARKERS OF ENDOTHELIAL PROGENITOR CELLS AND USES THEREOF
#853METHOD FOR DETECTING COLON CANCER
#854Depletion of mouse cells for isolation of human cells
#855BIOMARKERS OF IMMUNOMODULATORY EFFECTS IN HUMANS TREATED WITH ANTI-CD200 ANTIBODIES
#856Use of CD36 to identify cancer subjects for treatment
#857RHAMM binding peptides
#858Pre-eclampsia biomarkers
#859Process for assessing risk of substance administration
#860Biomarkers for radiation treatment
#861Endoglin antibodies
#862MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF DISEASES ASSOCIATED WITH EPITHELIAL MESENCHYMAL TRANSITION
#863Method for determining acute respiratory distress syndrome (ARDS) related biomarkers, a method to monitor the development and treatment of ARDS in a patient
#864Antibodies specific for CLL-1
#865CD31 peptides for the treatment of thrombotic or autoimmune disorders
#866NOVEL DISEASE-MARKER
#867Methods and materials for reducing suppression of immune function
#868Use of lymphocyte activation gene 3 (LAG-3) expression profiling as a biomarker for assessing inflammasomes, chronic inflammatory diseases and dysfunctional HDL
#869USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS
#870SYSTEM FOR DETECTION OF A COMPONENT IN A FLUID
#871MULTIPLEX ASSAY FOR IMPROVED SCORING OF TUMOR TISSUES STAINED FOR PD-L1
#872PD-L1 antibodies and uses thereof
#873Antibody binding specifically to human and mouse L1CAM protein, and use therefor
#874Compositions and methods for diagnosing and treating an inflammation
#875MCAM as a biomarker for fluid homeostasis
#876Azapeptides as CD36 binding compounds
#877Anti-DLL3 antibody drug conjugates
#878Detection Device for In Vivo and/or In Vitro Enrichment of Sample Material
#879Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis
#880GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF
#881Systems and methods for determining a chemical state
#882CD133 aptamers for detection of cancer stem cells
#883Medicament comprising activity modulator for CD300a-expressing cell associated with allergic disease, CD300a gene-deficient mouse, and use of activity modulator for CD300a-expressing cell
#884Agents that modulate immune cell activation and methods of use thereof
#885LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET
#886Systems and methods for detecting a biological condition
#887Diagnosis and risk stratification of bladder cancer
#888Systems, apparatus, and methods for sorting particles
#889HUMAN ENDOCRINE PROGENITORS FROM ADULT PANCREATIC TISSUE
#890Selective capture and stimulated release of circulating tumor cells on nanostructured devices
#891CLUSTER OF DIFFERENTIATION 36 (CD36) AS A THERAPEUTIC TARGET FOR HIV INFECTION
#892CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
#893Isolated cardiac stem cells and methods of their use
#894ISOLATION AND CHARACTERIZATION OF MUSCLE REGENERATING CELLS
#895Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS
#896Peptides that bind to epithelial cell adhesion molecule
#897Brown adipocyte progenitors in human skeletal muscle
#898Anti-presepsin antibody
#899MULTIPLEXED METHOD FOR DIAGNOSING CLASSICAL HODGKIN LYMPHOMA
#900Microfluidic system having a magnetic particle bed